PEG-Intron peginterferon alfa-2b infectious data

Data from an open-label, Italian trial in 283 patients showed that 12-week peginterferon alfa-2b and ribavirin combination therapy was as effective as 24-week therapy in HCV genotype 2 or 3 patients w...